Dec 17, 2020 10:10am EST 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
Dec 08, 2020 10:00am EST 22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
Nov 24, 2020 11:00am EST 22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
Nov 18, 2020 10:00am EST 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
Nov 16, 2020 9:45am EST 22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
Nov 05, 2020 7:00am EST 22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
Oct 22, 2020 10:00am EDT 22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A
Oct 19, 2020 10:00am EDT 22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference
Oct 14, 2020 1:00pm EDT 22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants
